The Federal Drug Enforcement Administration (DEA) has recently issued a Proposed Rule to temporarily place any non-scheduled ‘fentanyl-related’ substances (i.e., analogs) into Schedule I, effective January 29, 2018.
The DEA Administrator has announced that the placement of these synthetic opioids in Schedule I is necessary to avoid an imminent hazard to the public safety. Schedule I controlled substances require a special state license and DEA registration to obtain or store them for research purposes.
If you currently store an affected fentanyl analog in your laboratory, or need further assistance, please contact UMOR Controlled Substances Monitor Kelli Christman
at email@example.com or (734) 764-2003 for proper disposal instructions.